BB Biotech AG

Chart & performance

D1W1MN

P/E

5.34

P/S

40.21

EPS

10.48

Div yield, %

3.21%

Shrs. gr., 5y

-0.20%

Rev. gr., 5y

-35.71%

Revenues

Net income

CFO

Dividend

Mar 23, 20262.25 CHF/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

BB Biotech AG functions as an equity investment vehicle, managed by Bellevue Asset Management AG. Its investment mandate extends to publicly traded companies across the globe, with a particular focus on firms engaged in modern biotechnology for medications and diagnostic tools. The construction of its portfolio is driven by a rigorous fundamental analysis. This Swiss-domiciled entity was established on November 9, 1993.

URL

https://www.bbbiotech.ch/

IPO date

Nov 08, 2006

Employees

Domiciled in

Incorporated in

Valuation

No data to show